3 3 REFLECT CLINIC LIMITED 09171212 false 2023-08-01 2024-07-31 2024-07-31 The principal activity of the company is Specialists medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 09171212 2023-08-01 2024-07-31 09171212 2024-07-31 09171212 bus:OrdinaryShareClass1 2024-07-31 09171212 core:CurrentFinancialInstruments 2024-07-31 09171212 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 09171212 core:FurnitureFittingsToolsEquipment 2024-07-31 09171212 core:MotorVehicles 2024-07-31 09171212 bus:SmallEntities 2023-08-01 2024-07-31 09171212 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 09171212 bus:FilletedAccounts 2023-08-01 2024-07-31 09171212 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 09171212 bus:RegisteredOffice 2023-08-01 2024-07-31 09171212 bus:Director1 2023-08-01 2024-07-31 09171212 bus:Director2 2023-08-01 2024-07-31 09171212 bus:OrdinaryShareClass1 2023-08-01 2024-07-31 09171212 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 09171212 bus:Agent1 2023-08-01 2024-07-31 09171212 core:ComputerEquipment 2023-08-01 2024-07-31 09171212 core:FurnitureFittingsToolsEquipment 2023-08-01 2024-07-31 09171212 core:MotorVehicles 2023-08-01 2024-07-31 09171212 core:OfficeEquipment 2023-08-01 2024-07-31 09171212 countries:EnglandWales 2023-08-01 2024-07-31 09171212 2023-07-31 09171212 core:FurnitureFittingsToolsEquipment 2023-07-31 09171212 core:MotorVehicles 2023-07-31 09171212 2022-08-01 2023-07-31 09171212 2023-07-31 09171212 bus:OrdinaryShareClass1 2023-07-31 09171212 core:CurrentFinancialInstruments 2023-07-31 09171212 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 09171212 core:FurnitureFittingsToolsEquipment 2023-07-31 09171212 core:MotorVehicles 2023-07-31 09171212 bus:OrdinaryShareClass1 2022-08-01 2023-07-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 09171212

REFLECT CLINIC LIMITED

Unaudited Filleted Financial Statements

for the Year Ended 31 July 2024

 

REFLECT CLINIC LIMITED

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 8

 

REFLECT CLINIC LIMITED

Company Information

Directors

Joanna Lambe

Gerard Lambe

Registered office

64 Barrington Road
Altrincham
Greater Manchester
WA14 1HY

Accountants

Beans Accountants Ltd
Chartered AccountantSuite F/22
The White House
Greenalls Avenue
Warrington
Cheshire
WA4 6HL

 

REFLECT CLINIC LIMITED

(Registration number: 09171212)
Balance Sheet as at 31 July 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

5,082

7,472

Current assets

 

Debtors

5

38,869

75,320

Cash at bank and in hand

 

137,297

317,493

 

176,166

392,813

Creditors: Amounts falling due within one year

6

(73,057)

(117,973)

Net current assets

 

103,109

274,840

Net assets

 

108,191

282,312

Capital and reserves

 

Called up share capital

7

100

100

Retained earnings

108,091

282,212

Shareholders' funds

 

108,191

282,312

For the financial year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 3 April 2025 and signed on its behalf by:
 

.........................................
Joanna Lambe
Director

.........................................
Gerard Lambe
Director

 

REFLECT CLINIC LIMITED

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
64 Barrington Road
Altrincham
Greater Manchester
WA14 1HY
England

These financial statements were authorised for issue by the Board on 3 April 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

REFLECT CLINIC LIMITED

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024 (continued)

2

Accounting policies (continued)

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer Equipment

Straight line over 3 years

Motor Vehicle

Straight line over 4 years

Other capital assets

Straight line over 3 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

REFLECT CLINIC LIMITED

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024 (continued)

2

Accounting policies (continued)

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2023 - 3).

 

REFLECT CLINIC LIMITED

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024 (continued)

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 August 2023

23,451

51,490

74,941

Additions

1,828

-

1,828

At 31 July 2024

25,279

51,490

76,769

Depreciation

At 1 August 2023

16,352

51,117

67,469

Charge for the year

3,845

373

4,218

At 31 July 2024

20,197

51,490

71,687

Carrying amount

At 31 July 2024

5,082

-

5,082

At 31 July 2023

7,099

373

7,472

5

Debtors

Current

2024
£

2023
£

Prepayments

38,869

48,107

Other debtors

-

27,213

 

38,869

75,320

6

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Trade creditors

777

8,261

Taxation and social security

30,666

28,455

Other creditors

41,614

81,257

73,057

117,973

 

REFLECT CLINIC LIMITED

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024 (continued)

7

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

£1 Ordinary Shares of £1 each

100

100

100

100

       

8

Dividends

Interim dividends paid

2024
£

2023
£

Interim dividend of £2,645.00 (2023 - £1,280.00) per each £1 Ordinary Shares

264,500

128,000

 

 

9

Related party transactions

 

REFLECT CLINIC LIMITED

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024 (continued)

9

Related party transactions (continued)

Directors' remuneration

The directors' remuneration for the year was as follows:

2024
£

2023
£

Remuneration

29,330

12,570

Contributions paid to money purchase schemes

5,500

115,200

34,830

127,770